Antiplatelet effect of spironolactone via modulation of cPLA 2 -mediated thromboxane A 2 generation in murine platelets
Journal of Veterinary Science · 2026
DOI: 10.4142/jvs.26033 ↗At a glance
Journal article in Journal of Veterinary Science, 2026. Written by Sanggu Kim and 3 co-authors. Institution: Laboratory of Veterinary Pathology and Platelet Signaling, College of Veterinary Medicine, Chungbuk National University, Cheongju 28644, Korea. Major MEDLINE topics: Thromboxane A2, Spironolactone, Blood Platelets, Platelet Aggregation. 28 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Research Foundation of Korea, Ministry of Education, Chungcheongbuk-do.
Abstract (original language)
IMPORTANCE: Spironolactone, a steroidal aldosterone antagonist, is widely used as a diuretic and antihypertensive agent. Steroids have been known to promote thrombosis by directly increasing platelet count and activation and indirectly by increasing oxidative stress and suppressing nitric oxide synthesis. However, the effects of spironolactone on platelet activation remain unclear. OBJECTIVE: To investigate the effects of spironolactone on platelet function and underlying signaling mechanisms. METHODS: Platelet aggregation, dense granule secretion, thromboxane A₂ (TxA₂) generation, and protein phosphorylation were evaluated in platelets treated with spironolactone. RESULTS: Spironolactone significantly inhibited the secondary wave of platelet aggregation and dense granule secretion induced by 2-methylthioadenosine diphosphate (2-MeSADP). It is known that 2-MeSADP-induced secretion and the resultant secondary wave of aggregation depend on TxA₂-mediated positive feedback, suggesting a role for spironolactone in regulating TxA₂ generation in platelets. Additionally, spironolactone did not affect 2-MeSADP-induced platelet aggregation in aspirin-treated platelets in which TxA₂ generation was blocked. Furthermore, platelet aggregation and secretion induced by low concentrations of thrombin, which are also affected by TxA₂-mediated positive feedback, were partially inhibited by spironolactone. Notably, spironolactone significantly suppressed TxA₂ generation induced by both 2-MeSADP and thrombin. Finally, spironolactone markedly inhibited the 2-MeSADP- and thrombin-induced phosphorylation of cytosolic phospholipase A₂ (cPLA₂), extracellular signal-regulated kinase, and protein kinase B in non-aspirin-treated platelets, whereas only cPLA₂ phosphorylation was significantly inhibited in aspirin-treated platelets. CONCLUSIONS AND RELEVANCE: Spironolactone inhibits platelet activation by suppressing TxA₂ generation, primarily by modulating cPLA₂ phosphorylation, providing mechanistic insight into its effects on platelet signaling in vitro.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Laboratory of Veterinary Pathology and Platelet Signaling, College of Veterinary Medicine, Chungbuk National University, Cheongju 28644, Korea.
- Molecular Cardiology Research Institute, Tufts University School of Medicine, Boston, MA 02111, USA.
- Cancer Research Center, Chungbuk National University, Cheongju 28644, Korea. skim0026@cbu.ac.kr.
ORCID profiles: Sanggu Kim, Preeti Kumari Chaudhary, Seongmo Yang, Soochong Kim
Funding
- National Research Foundation of Korea
- Ministry of Education
- Chungcheongbuk-do
Cite
APA
Kim, S., Chaudhary, P. K., Yang, S., & Kim, S. (2026). Antiplatelet effect of spironolactone via modulation of cPLA 2 -mediated thromboxane A 2 generation in murine platelets. Journal of Veterinary Science. https://doi.org/10.4142/jvs.26033
Vancouver
Kim S, Chaudhary PK, Yang S, Kim S. Antiplatelet effect of spironolactone via modulation of cPLA 2 -mediated thromboxane A 2 generation in murine platelets. Journal of Veterinary Science. 2026. doi:10.4142/jvs.26033
BibTeX
@article{Kim2026,
author = {Kim, Sanggu and Chaudhary, Preeti Kumari and Yang, Seongmo and Kim, Soochong},
title = {Antiplatelet effect of spironolactone via modulation of cPLA 2 -mediated thromboxane A 2 generation in murine platelets},
journal = {Journal of Veterinary Science},
year = {2026},
doi = {10.4142/jvs.26033}
}
EUVIMED